Association of cyclophilin A with renal brush border membranes: Redistribution by cyclosporine A

Kidney International

Volumn 57, Issue 4, 2000, Pages 1590-1598

  Demeule, Michel ^a,b,c   Laplante, Alain ^a,b,c   Sepehr Araé, Arash ^a,b,c   Murphy, Gérard M ^a,b,c   Wenger, Roland M ^a,b,c   Béliveau, Richard ^a,b,c  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b Novartis Pharma Canada Inc   (Canada)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cyclophilins; Immunosuppression; Nephrotoxicity; Protein folding; Renal cortex

Indexed keywords

CYCLOPHILIN A; CYCLOSPORIN A;

BRUSH BORDER; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; IMMUNOASSAY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0034036607     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00003.x     Document Type: Conference Paper

References (39)

1. 1. HANDSCHUMACHER RE, HARDING MW, RICE J, DRUGGE RJ, SPEICHER DW: Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 226:544-547, 1984
2. 2. SIEKIERKA JJ, STARUCH MJ, HUNG SH, SIGAL NH: FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporine A-binding protein, cyclophilin. J Immunol 143:1580-1583, 1989
3. 3. LIU J: FK506 and cyclosporin: Molecular probes for studying intracellular signal transduction. Trends Pharmacol Sci 14:182-188, 1993
4. 4. BIERER BE: Cyclosporin A, FK506, and rapamycin: Binding to immunophilins and biological action. Chem Immunol 59:128-155, 1994
5. 5. FRIEDMAN J, WEISSMAN I: Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA. Cell 66:799-806, 1991
6. 6. PRICE ER, ZYDOWSKY LD, JIN MJ, BAKER CH, MCKEON FD, WALSH CT: Human cyclophilin B: A second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc Natl Acad Sci USA 88:1903-1907, 1991
7. 7. DUMONT FJ: Mechanisms of action of cyclosporine A and tacrolimus (FK506): Immunosuppression through immunophilin-dependent inhibition of calcineurin function, in Principles of Drug Development in Transplantation and Autoimmunity, edited by LIEBERMAN R, MUKHERJEE A, Philadelphia, Lippincott Williams & Wilkins, 1996, pp 133-155
8. 8. HALESTRAP AP, CONNERN CP, GRIFFITHS EJ, KERR PM: Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 174:167-172, 1997
9. 9. UITTENBOGAARD A, YING Y, SMART EJ: Characterization of a cytosolic heat-shock protein-caveolin chaperone complex: Involvement in cholesterol trafficking. J Biol Chem 273:6525-6532, 1998
10. 10. FRUMAN DA, KLEE CB, BIERER BE, BURAKOFF SJ: Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc Natl Acad Sci USA 89:3686-3690, 1992
11. 11. SWANSON SK, BORN T, ZYDOWSKY LD, CHO H, CHANG HY, WALSH CT, RUSNAK F: Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci USA 89:3741-3745, 1992
12. 12. FISCHER G, WITTMAN-LIEBOLD B, LANG K, KIEFHABER T, SCHMID FX: Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476-478, 1989
13. 13. TAKAHASHI N, HAYANO T, SUZUKI M: Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337:473-475, 1989
14. 14. CARDENA ME, HEMENWAY C, MUIR RS, YE R, FIORENTINO D, HEITMAN J: Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J 24:5944-5957, 1994
15. 15. FRESKGARD PO, BERGENHAM N, JONSSON BH, SVENSSON M, CARLSSON U: Isomerase and chaperone activity of prolyl isomerase in the folding of carbonic anhydrase. Science 258:467-468, 1992
16. 16. SIGAL NH, DUMONT F, DURETTE P, SIEKIERKA JJ, PETERSON L, RICH DH, DUNLAP BE, STARUCH MJ, MELINO MR, KOPRAK SL, WILLIAMS D, WITZEL B, PISANO JM: Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J Exp Med 173:619-628, 1991
17. 17. BOREL JF, KIS ZL: The discovery and development of cyclosporine A (Sandimmune). Transplant Proc 23:1867-1874, 1991
18. 18. HO S, CLIPSTONE N, TIMMERMANN L, NORTHROP J, GRAEF I, FIORENTINO D, NOURSE J, CRABTREE GR: The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40-S45, 1996
19. 19. RYFFEL B, WOERLY G, GREINER B, HAENDLER B, MIHATSCH MJ, FOXWELL BMJ: Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 72:399-404, 1991
20. 20. MARKS WH, HARDING MW, HANDSCHUMACHER R, MARKS C, LORBER MI: The immunochemical distribution of cyclophilin in normal mammalian tissues. Transplantation 52:340-345, 1991
21. 21. FRIEDMAN J, WEISSMAN I, FRIEDMAN J, ALPERT S: An analysis of the expression of cyclophilin C reveals tissue restriction and an intriguing pattern in the mouse kidney. Am J Pathol 144:1247-1256, 1994
22. 22. SU Q, WEBER L, LE HIR M, ZENKE G, RYFFEL B: Nephrotoxicity of cyclosporin A and FK506: Inhibition of calcineurin phosphates. Renal Physiol Biochem 18:128-139, 1995
23. 23. JETTÉ. L, BEAULIEU É, LECLER JM, BÉLIVEAU R: Cyclosporin A treatment induces overexpression of P-glycoprotin in the kidney and other tissues. Am J Physiol 270:F756-F765, 1996
24. 24. LAEMMLI UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
25. 25. BRADFORD MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
26. 26. ROMANO JD, SCHMIDT WK, MICHAELIS S: The saccharomyces cerevisiac prenylcysteine carboxyl methyltransferase Ste14p is in the endoplasmic reticulum membrane. Mol Biol Cell 9:2231-2247, 1998
27. 27. GINGRAS D, BOIVIN D, BÉLIVEAU R: Subcellular distribution and guanine nucleotide dependency of COOH-terminal methylation in kidney cortex. Am J Physiol 265:F316-F322, 1993
28. 28. GORDON JA, GATTONE VH II: Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol 250:F991-F998, 1986
29. 29. KUHLMANN MK, BURKHARDT G, KÖHLER H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 12:2478-2480, 1997
30. 30. DEMEULE M, BROSSARD M, BÉLIVEAU R: Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 277(6 Pt 2):F832-F840, 1999
31. 31. KOLETSKY AJ, HARDING MW, HANDSCHUMACHER RE: Cyclophilin: Distribution and variant properties in normal and neoplastic tissues. J Immunol 137:1054-1059, 1986
32. 32. SARRIS AH, HARDING MW, JIANG TR, AFTAB D, HANDSCHUMACHER RE: Immunofluorescent localization and immunochemical determination of cyclophilin-A with specific rabbit antisera. Transplantation 54:904-910, 1992
33. 33. BOIVIN D, BÉLIVEAU R: Subcellular distribution and membrane association of Rho-related small GTP-binding proteins in kidney cortex. Am J Physiol 38:F180-F189, 1995
34. 34. THALHAMMER T, KIEFFER LJ, JIANG T, HANDSCHUMACHER RE: Isolation and partial characterization of membrane-associated cyclophilin and a related 22 kDa glycoprotein. Eur J Biochem 206:31-37, 1992
35. 2+]. Biochemistry 25:8172-8180, 1996
36. 36. MCDONALD ML, ARDITO T, MARKS WH, KASHGARIAN M, LORBER MI: The effect of cyclosporine administration on the cellular distribution and content of cyclophilin. Transplantation 53:460-466, 1992
37. 37. DEMEULE M, LAPLANTE A, MURPHY GF, WENGER RM, BÉLIVEAU R: Identification of the cyclosporin A-binding site in P-glycoprotein. Biochemistry 37:18110-18118, 1999
38. 38. DEMEULE M, BÉLIVEAU R: Cyclosporin inhibits phosphate transport and stimulates alkaline phosphatase activity in renal brush border membrane vesicles. Am J Physiol 260:F518-F524, 1991
39. 39. HASEL KW, GLASS JR, GODBOUI M, SUTCLIFFE JG: An endoplasmic reticulum-specific cyclophilin. Mol Cell Biol 11:3483-3491, 1991